基于FAERS数据库的Definity不良反应真实世界药物警戒研究
本研究利用美国FDA不良事件报告系统(FAERS)数据,采用报告比值比(ROR)、比例报告比(PRR)、贝叶斯置信传播神经网络(BCPNN)和经验贝叶斯几何均值(EBGM)等不成比例分析算法,识别Definity超声造影剂相关的不良反应。报告病例数最多的前五个SOC包括肌肉骨骼与结缔组织疾病、心脏疾病、免疫系统疾病、呼吸系统/胸及纵隔疾病以及全身性疾病与给药部位反应。结论强调需警惕超敏反应和心肺反应,并建议进一步研究其临床相关性。
要点
- Definity相关不良反应涉及10个SOC,以肌肉骨骼、心脏、免疫、呼吸和全身性反应为主。
- 临床使用Definity时应警惕过敏反应和心肺事件,加强用药后监测。
核心结论
- Definity相关不良反应以超敏反应和心肺反应为重要信号,需加强临床监测并进一步研究其临床相关性。
研究设计与样本
- 基于FAERS数据库的真实世界药物警戒研究,采用不成比例分析(ROR、PRR、BCPNN、EBGM)识别Definity相关ADRs。
- 共纳入1522例归因于Definity的不良事件报告。
主要发现
- 报告病例数最多的前五个SOC为肌肉骨骼与结缔组织疾病、心脏疾病、免疫系统疾病、呼吸系统/胸及纵隔疾病、全身性疾病与给药部位反应。
临床怎么用
- 使用Definity进行超声造影时,应特别关注超敏反应和心肺相关不良事件,并做好监测与应急准备。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Definity, an ultrasound contrast agent (UCA), is widely utilized in echocardiography. Real-world studies on the safety of Definity in large populations are still lacking. This study aims to explore Definity-related adverse events via real-world data from the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS). METHODS: We adopted disproportionality analysis to identify significant adverse drug reactions (ADRs) related to Definity by utilizing algorithms like reporting odds ratio (ROR), roportional reporting ratio (PRR), Bayesian confidence propagation neural network (BCPNN), and the empirical Bayes geometric mean (EBGM). RESULTS: In our analysis, there were 1522 cases specifically attributed to Definity. Thirty-five Definity-related preferred terms (PTs) across 10 system organ classes (SOCs) were identified through disproportionality analysis. The top five SOCs with the highest reported cases included "Musculoskeletal and connective tissue disorders", "Cardiac disorders", "Immune system disorders", "Respiratory, thoracic and mediastinal disorders" and "General disorders and administration site conditions." CONCLUSIONS: This real-world pharmacovigilance study has identified vital ADRs linked to Definity, particularly hypersensitivity-mediated and cardiopulmonary reactions, underscoring the need for vigilant monitoring and further studies to clarify their clinical relevance.
引用
- Lin W, Lin Y, Xu S, et al. Exploring Definity-related adverse reaction: A real-world pharmacovigilance study via FAERS database analysis. Br J Clin Pharmacol. 2025. PMID: 40974233. doi:10.1002/bcp.70295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。